Higher revenues fail to save Hofseth BioCare from deeper Q2 losses

Losses continued to mount during the first half of 2021.

Roger Hofseth is encouraged by the company's increase in revenues, but losses still hamper the company. — Roger Hofseth is encouraged by the company's increase in revenues, but losses still hamper the company.Foto: Hyperthermics

John Fiorillo

Published 30 August 2021, 04:06Updated 30 August 2021, 04:06

Hofseth Biocare Roger Hofseth Pet food Earnings